These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 29912214)
21. Medications for Alcohol Use Disorder. Poorman E; McQuade BM; Messmer S Am Fam Physician; 2024 Jan; 109(1):71-78. PubMed ID: 38227873 [TBL] [Abstract][Full Text] [Related]
22. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Heilig M; Egli M Pharmacol Ther; 2006 Sep; 111(3):855-76. PubMed ID: 16545872 [TBL] [Abstract][Full Text] [Related]
23. Medications for treating alcohol dependence. Williams SH Am Fam Physician; 2005 Nov; 72(9):1775-80. PubMed ID: 16300039 [TBL] [Abstract][Full Text] [Related]
24. Anticraving therapy for alcohol use disorder: A clinical review. Shen WW Neuropsychopharmacol Rep; 2018 Sep; 38(3):105-116. PubMed ID: 30175522 [TBL] [Abstract][Full Text] [Related]
25. Advances in Pharmacotherapy Development: Human Clinical Studies. Litten RZ; Falk DE; Ryan ML; Fertig J; Leggio L Handb Exp Pharmacol; 2018; 248():579-613. PubMed ID: 29294197 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials. Falk DE; O'Malley SS; Witkiewitz K; Anton RF; Litten RZ; Slater M; Kranzler HR; Mann KF; Hasin DS; Johnson B; Meulien D; Ryan M; Fertig J; JAMA Psychiatry; 2019 Apr; 76(4):374-381. PubMed ID: 30865232 [TBL] [Abstract][Full Text] [Related]
27. Review article: pharmacotherapy for alcohol dependence - the why, the what and the wherefore. Goh ET; Morgan MY Aliment Pharmacol Ther; 2017 Apr; 45(7):865-882. PubMed ID: 28220511 [TBL] [Abstract][Full Text] [Related]
28. Acamprosate campral for alcoholism. Med Lett Drugs Ther; 2005 Jan; 47(1199):1-3. PubMed ID: 15599336 [TBL] [Abstract][Full Text] [Related]
29. [Pharmacological review of alcoholic dependence treatment]. Oural L; Paris MV; Sullivan O; Polach M; Pavlovsky F; Capece J Vertex; 2008; 19(77):512-21. PubMed ID: 18443665 [TBL] [Abstract][Full Text] [Related]
30. Strategies to increase implementation of pharmacotherapy for alcohol use disorders: a structured review of care delivery and implementation interventions. Williams EC; Matson TE; Harris AHS Addict Sci Clin Pract; 2019 Feb; 14(1):6. PubMed ID: 30744686 [TBL] [Abstract][Full Text] [Related]
31. Does the alcoholic's remedy come in a pill? Gordon SM Behav Healthc Tomorrow; 2001 Aug; 10(4):SR29-30, SR34. PubMed ID: 11496583 [No Abstract] [Full Text] [Related]
32. Perspectives on the pharmacological management of alcohol use disorder: Are the approved medications effective? Antonelli M; Sestito L; Tarli C; Addolorato G Eur J Intern Med; 2022 Sep; 103():13-22. PubMed ID: 35597734 [TBL] [Abstract][Full Text] [Related]
33. Real-world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation-wide cohort of 125 556 patients. Heikkinen M; Taipale H; Tanskanen A; Mittendorfer-Rutz E; Lähteenvuo M; Tiihonen J Addiction; 2021 Aug; 116(8):1990-1998. PubMed ID: 33394527 [TBL] [Abstract][Full Text] [Related]
35. [Use of drugs for alcohol use disorder in Norway 2004–16]. Heldal AT; Skurtveit S; Lobmaier PPK; Vederhus JK; Bramness JG Tidsskr Nor Laegeforen; 2018 Nov; 138(18):. PubMed ID: 30421743 [TBL] [Abstract][Full Text] [Related]
36. Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies. Leggio L; Falk DE; Ryan ML; Fertig J; Litten RZ Handb Exp Pharmacol; 2020; 258():443-462. PubMed ID: 31628604 [TBL] [Abstract][Full Text] [Related]
37. Naltrexone in alcohol dependence. Brewer C Lancet; 1995 Nov; 346(8986):1374. PubMed ID: 7475809 [No Abstract] [Full Text] [Related]
38. Drug adjuncts for treating alcohol dependence. Collins GB; McAllister MS; Adury K Cleve Clin J Med; 2006 Jul; 73(7):641-4, 647-8, 650-1, passim. PubMed ID: 16845975 [TBL] [Abstract][Full Text] [Related]
39. Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France. Chaignot C; Zureik M; Rey G; Dray-Spira R; Coste J; Weill A Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1239-1248. PubMed ID: 30251424 [TBL] [Abstract][Full Text] [Related]
40. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders. Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Rounsaville B; Biol Psychiatry; 2005 May; 57(10):1128-37. PubMed ID: 15866552 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]